IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Immuron Ltd
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026
$0.96−0.03 (-2.62%)
Close on Oct 19, 2026
Immuron statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Immuron | Industry median |
|---|---|---|
| Market Cap | A$11.06M | A$18.21M |
| Enterprise Value | A$2.04M | A$11.71M |
| PS Ratio | 1.43 |
Enterprise value
| Measure | Immuron | Industry median |
|---|---|---|
| EV / Sales | 0.26 |
Income (trailing twelve months)
| Measure | Immuron | Industry median |
|---|---|---|
| Revenue | A$7.71M | |
| Gross Profit | A$4.98M | |
| Operating Income | -A$3.85M | |
| Pretax Income | -A$3.68M | -A$22.45M |
| Net Income | -A$3.68M | |
| EBITDA | -A$3.81M | |
| EPS (Diluted) | -1.24 AUD |
Margins
| Measure | Immuron | Industry median |
|---|---|---|
| Gross Margin | 64.5% | |
| Operating Margin | -49.9% | |
| Pretax Margin | -47.7% | |
| Profit Margin | -47.7% | |
| EBITDA Margin | -49.4% | |
| FCF Margin | -42.3% |
Returns
| Measure | Immuron | Industry median |
|---|---|---|
| Return on Assets (ROA) | -31.6% | |
| Return on Capital Employed (ROCE) | -33.9% |
Growth
| Measure | Immuron | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 5.85% | |
| Revenue Growth (3Y CAGR) | 62.3% | |
| Revenue Growth (5Y CAGR) | 121.2% |
Balance sheet
| Measure | Immuron | Industry median |
|---|---|---|
| Cash & Short-Term Investments | A$9.02M | A$37.32M |
| Net Cash (Debt) | A$9.02M | A$37.32M |
| Net Cash Per Share | 0.03 AUD | 0.05 AUD |
| Working Capital | A$11.17M | A$42.67M |
Financial position
| Measure | Immuron | Industry median |
|---|---|---|
| Current Ratio | 7.26 | 7.26 |
| Quick Ratio | 5.84 | 5.84 |
| Interest Coverage | -261.74 |
Cash flow (trailing twelve months)
| Measure | Immuron | Industry median |
|---|---|---|
| Operating Cash Flow | -A$3.26M | -A$13.28M |
| Capital Expenditures | -A$4.75K | |
| Free Cash Flow | -A$3.26M | |
| FCF Per Share | -0.01 AUD |
Efficiency
| Measure | Immuron | Industry median |
|---|---|---|
| Asset Turnover | 0.66 | |
| Inventory Turnover | 1.35 | |
| Revenue Per Employee | A$1.10M | |
| Profits Per Employee | -A$525.71K | |
| Employee Count | 7 |
Dividends and yields
| Measure | Immuron | Industry median |
|---|---|---|
| Earnings Yield | -33.3% | |
| FCF Yield | -29.5% |
Shares
| Measure | Immuron | Industry median |
|---|---|---|
| Shares Outstanding | 322,848,000 | 322,848,000 |
| Shares Change (YoY) | 28.6% | 28.6% |
| Float | 316,596,000 | 316,596,000 |
| Shares Held by Insiders | 1.94% | 1.94% |
| Shares Held by Institutions | 0.02% |
Scores
| Measure | Immuron | Industry median |
|---|---|---|
| Altman Z-Score | -5.06 | -0.54 |
| Piotroski F-Score | 5 |
Calculated by StockData from Immuron's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.